BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17981643)

  • 1. Factors regulating apoptosis and homeostasis of CD4+ CD25(high) FOXP3+ regulatory T cells are new therapeutic targets.
    Yang XF
    Front Biosci; 2008 Jan; 13():1472-99. PubMed ID: 17981643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
    Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
    PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo.
    Wu T; Zhang L; Xu K; Sun C; Lei T; Peng J; Liu G; Wang R; Zhao Y
    Transpl Immunol; 2012 Aug; 27(1):30-8. PubMed ID: 22613676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells.
    Turka LA; Walsh PT
    Front Biosci; 2008 Jan; 13():1440-6. PubMed ID: 17981641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
    Wang ZH; Zhu JY; Li T; Leng XS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
    Brode S; Raine T; Zaccone P; Cooke A
    J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.
    Taylor AL; Llewelyn MJ
    J Immunol; 2010 Dec; 185(11):6591-8. PubMed ID: 21048104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
    Matsuoka K; Kim HT; McDonough S; Bascug G; Warshauer B; Koreth J; Cutler C; Ho VT; Alyea EP; Antin JH; Soiffer RJ; Ritz J
    J Clin Invest; 2010 May; 120(5):1479-93. PubMed ID: 20389017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and genomic analyses of FOXP3-transduced Jurkat-T cells as regulatory T (Treg)-like cells.
    Kim JY; Kim HJ; Hurt EM; Chen X; Howard OMZ; Farrar WL
    Biochem Biophys Res Commun; 2007 Oct; 362(1):44-50. PubMed ID: 17706604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
    Moorman JP; Wang JM; Zhang Y; Ji XJ; Ma CJ; Wu XY; Jia ZS; Wang KS; Yao ZQ
    J Immunol; 2012 Jul; 189(2):755-66. PubMed ID: 22706088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling.
    Oberle N; Eberhardt N; Falk CS; Krammer PH; Suri-Payer E
    J Immunol; 2007 Sep; 179(6):3578-87. PubMed ID: 17785792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interleukin 4 on CD25+CD4+ regulatory T cell function.
    Maerten P; Shen C; Bullens DM; Van Assche G; Van Gool S; Geboes K; Rutgeerts P; Ceuppens JL
    J Autoimmun; 2005 Sep; 25(2):112-20. PubMed ID: 16051465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of T-regulatory cells in pregnancy and cancer.
    Wilczynski JR; Kalinka J; Radwan M
    Front Biosci; 2008 Jan; 13():2275-89. PubMed ID: 17981709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents.
    Ohkura N; Hamaguchi M; Sakaguchi S
    Trends Pharmacol Sci; 2011 Mar; 32(3):158-66. PubMed ID: 21237521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus.
    Lyssuk EY; Torgashina AV; Soloviev SK; Nassonov EL; Bykovskaia SN
    Adv Exp Med Biol; 2007; 601():113-9. PubMed ID: 17712998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The control of CD4+CD25+Foxp3+ regulatory T cell survival.
    Pandiyan P; Lenardo MJ
    Biol Direct; 2008 Feb; 3():6. PubMed ID: 18304352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
    Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
    Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.
    Longhi MS; Hussain MJ; Mitry RR; Arora SK; Mieli-Vergani G; Vergani D; Ma Y
    J Immunol; 2006 Apr; 176(7):4484-91. PubMed ID: 16547287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.